Kalkine has a fully transformed New Avatar.

small-cap

Punt On This NYSE-Listed Specialty Chemical Stock - ASIX

Jun 22, 2022 | Team Kalkine
Punt On This NYSE-Listed Specialty Chemical Stock - ASIX

 

AdvanSix Inc.

ASIX Details

 

AdvanSix Inc. (NYSE: ASIX) is an integrated producer of fertilizers and the polymer resin Nylon 6. Customers utilize nylon six as a synthetic material to make engineered plastics, fibres, filaments, and films, which are then used to create end goods, including carpets, sportswear, fishing nets, food packaging, and industrial and automotive components. It also offers a range of other goods, such as caprolactam, fertilizers made of ammonium sulphate, and other chemical intermediates. Geographically, It works throughout the United States, and its business is also growing elsewhere.

Latest Developments

  • Completed Acquisition of U.S. Amines: In Q1FY22 ended March 31, 2022, the company closed acquisition of U.S. Amines, a leading North American producer of high-value intermediates used in agrochemicals, pharmaceuticals, and other applications for an estimated net purchase price of ~US 98 million.
  • Stock Buy Back: In the quarter just gone by the company repurchased 181,536 shares at an average share price of USD 38.61 for approximately USD 7 million.

Financial Highlights: Q1FY22

Source: Company Presentation 

  • Solid topline performance: During the Q1FY22, the company reported strong topline performance on a YoY basis, with sales surged by 27% to USD 479 million, on the back of 26% jump in favorable impact of market-based pricing, 3% higher raw material pass-through pricing, and 2% contribution from acquisitions, partially offset by 4% lower volume.
  • Strong operating performance: During the quarter under consideration, the company’s Adjusted EBITDA was of USD 103.2 million, an increase of USD 45.6 million on a YoY basis. Adjusted EBIDTA margin stood at 21.5%, a jump of 620bps on a YoY basis.
  • Increase in Capex: In Q1FY22, the company’s Capex stood at USD 21.0 million, an increase of USD 6.8 million from the same quarter of the previous financial year.

Key Risks:

  • Hike in Natural Gas and Sulphur Prices: The company's financials will be directly impacted by the global increase in natural gas and Sulphur prices. Additionally, the facility was completely shut down because of a fire at the Freeport LNG natural gas liquefaction plant in South Texas on June 8, 2022. It will result in a 2 billion cubic foot per day reduction in the entire U.S. LNG export capacity.
  • Competition Risk: AdvanSix faces competition from integrated manufacturers and fierce rivalry from DOMO Chemicals GmbH, LANXESS AG, BASF Corporation, Ube Industries Ltd., and Highsun Group Holdings Ltd. in each of the key product categories.

Outlook:

Well Positioned to Deliver Sustainable Performance and Attractive Returns Over Long-Term.

(Source: Company Filings)

Valuation Methodology: E.V./Sales Multiple Based Relative Valuation:

Source: REFINITIV, Analysis: Kalkine Group

Stock Recommendation:

ASIX delivered robust Q1FY22 to start FY22, delivering both sequential and YoY top and bottom-line growth. Company’s collective organization contributed to achieving record sales, earnings and margins in the quarter reflecting the advantage of their diverse portfolio, as well as disciplined execution to serve its key customers and meet strong end market demand amid a tightened supply environment

Currently, the ASIX is trading towards the low end of its 52-week trading range of USD 57.10 to USD 27.54. On weekly price chart, ASIX shares are forming a Double-Bottom pattern, a pullback is expected from the current level. Further, on weekly chart stock is hovering near the lower band of the Bollinger Band©, indicates that a pullback is possible from the current levels. However, long-term trend is bearish, but the stock is hovering near strong demand zone.

Considering the robust top-line and Bottom-line performance, positive outlook, industry above margins, higher ROE, associated risks, technical pattern, and current valuation. We recommend a "Speculative Buy" rating on the stock at the current price of USD 32.80 as of June 22, 2022, at 06:55 AM PDT.

1-year technical chart as of June 22, 2022, at 06:55 AM PDT. Source: REFINITIV. Analysis by Kalkine group

Technical Analysis Summary:

Technical Indicators Defined: -

Support: A level where-in the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest.

Resistance: A level where-in the stock prices tend to find resistance when they are rising, and the uptrend may take a pause due to profit booking or selling interest.

Stop-loss: It is a level to protect further losses in case of unfavorable movement in the stock prices.

Note 1: The reference data in this report has been partly sourced from REFINITIV.  

Note 2: Investment decisions should be made depending on the investors' appetite for upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting the stock if the Target Price mentioned as per the valuation has been achieved and subject to the factors discussed above. 

Note 3: The report publishing date is as per the Pacific Time Zone.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.